Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-08-02

FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application for Flonase Sensimist Allergy Relief containing fluticasone furoate, filed by Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLONASE SENSIMIST ALLERGY RELIEF (Fluticasone furoate)

Snippet

SUPPL AP for FLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE)